Neurology | Physician's Weekly
Advertisement

Neurology

Deutetrabenazine No Help for Tourette Tics

Phase III study fails after promising early data Deutetrabenazine was not effective in treating tics associated with Tourette syndrome, the phase III ARTISTS 2 trial found.At week 8, the difference in Yale Global Tic Severity...

Some MS Drugs Attenuate Covid-19 Vaccine Response

Vaccination timing, additional doses merit consideration Some disease-modifying treatments (DMTs) used in multiple sclerosis (MS) may attenuate patients’ immune response to SARS-CoV-2 vaccination.The American Academy of...

Loading